Domača stranVCEL • NASDAQ
add
Vericel Corp
59,50 $
Pred odprtjem:(3,38 %)−2,01
57,49 $
Konec trgovanja: 13. jan., 04:00:45 GMT -5 · USD · NASDAQ · Izjava
Prejšnji trg. dan.
59,53 $
Dnevni razpon
57,58 $ - 60,13 $
Letni razpon
36,35 $ - 60,16 $
Tržna kapitalizacija
2,94 mrd. USD
Povprečni obseg
349,90 tis.
Razm. P/E
769,13
Dividendna donosnost
-
Primarna borza
NASDAQ
Borzne novice
Investing.com
pred 37 minutami
Morning Bid: S&P500 wipes post-election gains as bonds haunt By Reuters
1,54 %
Finančni podatki
Izkaz poslovnega izida
Prihodek
Čisti dohodek
| (USD) | sep. 2024info | Sprememba L/L |
|---|---|---|
Prihodek | 57,90 mio. | 27,04 % |
Stroški poslovanja | 44,12 mio. | 23,70 % |
Čisti dohodek | −901,00 tis. | 75,38 % |
Čista dobičkovnost prihodkov | −1,56 | 80,57 % |
Earnings per share | 0,02 | 136,80 % |
EBITDA | −1,14 mio. | 70,82 % |
Efektivna davčna stopnja | — | — |
Bilanca stanja
Skupna sredstva
Skupne obveznosti
| (USD) | sep. 2024info | Sprememba L/L |
|---|---|---|
Denar. in kratkor. naložbe | 101,73 mio. | −3,43 % |
Skupna sredstva | 390,40 mio. | 22,72 % |
Skupne obveznosti | 132,93 mio. | 16,87 % |
Celoten lastniški kapital | 257,47 mio. | — |
Shares outstanding | 49,36 mio. | — |
Razmerje P/B | 11,38 | — |
Donosnost sredstev | −1,61 % | — |
Donosnost kapitala | −1,78 % | — |
Denarni tok
Neto sprememba denarnih sredstev
| (USD) | sep. 2024info | Sprememba L/L |
|---|---|---|
Čisti dohodek | −901,00 tis. | 75,38 % |
Denar iz dejavnosti | 10,18 mio. | 42,06 % |
Denar iz naložb | −21,21 mio. | −564,56 % |
Denar iz financiranja | 5,52 mio. | 447,47 % |
Neto sprememba denarnih sredstev | −5,50 mio. | −143,19 % |
Prost denarni tok | −5,60 mio. | −200,17 % |
Vizitka
Vericel Corporation is a publicly traded American biopharmaceutical company which was known prior to October 2014 as Aastrom Bio. Aastrom Bio was formed in 1989 in Ann Arbor, Michigan.
In the spring of 2014, Aastrom Bio acquired Sanofi's cell therapy and regenerative medicine business which Sanofi had acquired when purchasing Genzyme in 2011. This transformed Aastrom in several ways: it increased the employee count by 8-fold and provided a revenue stream and products to market, which it had not had before.
In October 2014, the company changed its name from Aastrom Bio to Vericel and relocated its headquarters from Ann Arbor, Michigan to Cambridge, Massachusetts. Wikipedia
Generalni direktor
Datum ustanovitve
1989
Sedež organizacije
Spletno mesto
Zaposleni
314
